1. 注射用利培酮微球临床应用 专家共识.
- Author
-
司天梅
- Abstract
Risperidone microspheres for injection, as the first long-acting injection of the second generation antipsychotic drugs in China, combines the advantages of long-acting dosage forms and atypical antipsychotics, and had accumulated rich clinical application experience for more than ten years, bringing significant clinical benefits to schizophrenia patients. On the basis of the Expert Opinions on Clinical Application of Atypical Long-acting Injection (Risperidone Microspheres for Injection) in 2012, experts organized by Schizophrenia Collaboration Group of the Chinese Psychiatry Society systematically summarized the latest guidelines and evidence-based evidence at home and abroad, and combined with the clinical practice in China, formulated the Expert Consensus on Clinical Application of Risperidone Microspheres for Injection, aiming at improving the scientific and normative clinical use of risperidone microspheres for injection and providing better clinical medication guidance for clinicians. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF